Targeted molecular characterization shows differences between primary and secondary myelofibrosis.
Frédéric CourtierSéverine GarnierNadine CarbucciaArnaud GuilleJosé AdélaideMax ChaffanetPierre HirschDamien Luque PazBohrane SlamaNorbert VeyValérie UgoFrançois DelhommeauJérome ReyDaniel BirnbaumAnne MuratiPublished in: Genes, chromosomes & cancer (2019)
PMF and SMF have different but not specific molecular profiles and different prognosis depending on the molecular profile. This may be due to differences in disease history. Combining mutations and existing scores should improve prognosis assessment.